Associate Professor of Neurology, Division of Concussion, Division of Headache, Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
RK Consults, Ozark, MO, United States.
Pain Manag. 2024;14(7):335-345. doi: 10.1080/17581869.2024.2392466. Epub 2024 Sep 18.
WHAT IS THIS SUMMARY ABOUT?: The Harris Poll Migraine Report Card was a survey about people's experiences and challenges with headaches and migraine. The survey was conducted from December 9, 2021, to January 10, 2022, in the United States. The people who took the survey had frequent headaches/migraine attacks (on 8 or more days per month) and used acute headache/migraine medication to relieve head pain and other symptoms (on 10 or more days per month). This summary focuses on the responses of adults with frequent headaches and frequent acute medication use at the time of the survey or within the few months (not specified) before the survey (and not those who previously had frequent headaches and frequent acute medication use at some point in their life prior to the survey). The group of people who took the survey will be called 'respondents'. The term 'headaches' can mean any type of headache including as part of a migraine attack, a tension type headache, or another unknown headache type. All respondents screened positive for having migraine, so many of the headaches they reported on may have been a migraine headache or part of a migraine attack.
WHAT WERE THE RESULTS?: Over 50% of respondents said their headaches affected their overall quality of life. Many respondents wished their healthcare provider who was managing their headaches understood more about how headaches affect their mental well-being, how much pain their headaches cause, and why they get headaches. 80% of respondents had concerns about their overall health. Over 60% of respondents said they have experienced anxiety and/or depression. In this survey, although all respondents were eligible to receive a preventive headache/migraine medication because of their headache frequency, only 15% were taking one.
WHAT DO THE RESULTS OF THE SURVEY MEAN?: The findings from this survey showed many ways that headaches/migraine care can improve, including talking about mental and emotional well-being, making sure the treatment plan works and does not have side effects that cannot be tolerated, and trying to prevent headaches/migraine from occurring.
这份报告卡调查了人们在头痛和偏头痛方面的经历和面临的挑战。调查于 2021 年 12 月 9 日至 2022 年 1 月 10 日在美国进行。接受调查的人每月有 8 天或更多天经常头痛/偏头痛发作（每月有 8 天或更多天经常头痛/偏头痛发作），每月有 10 天或更多天使用急性头痛/偏头痛药物来缓解头痛和其他症状（每月有 10 天或更多天使用急性头痛/偏头痛药物来缓解头痛和其他症状）。这份报告卡主要关注的是在调查时或调查前几个月（未具体说明）经常使用急性头痛/偏头痛药物缓解头痛的受访者的反应（而不是那些在调查前的某个时候曾经常使用急性头痛/偏头痛药物缓解头痛的人）。接受调查的人将被称为“受访者”。“头痛”一词可指任何类型的头痛，包括偏头痛发作时的头痛、紧张性头痛或其他未知的头痛类型。所有接受调查的人都被筛查出患有偏头痛，因此他们报告的许多头痛可能是偏头痛头痛或偏头痛发作的一部分。
超过 50%的受访者表示，他们的头痛影响了整体生活质量。许多受访者希望他们治疗头痛的医疗保健提供者更了解头痛如何影响他们的心理健康、头痛给他们带来的疼痛程度以及他们为何会头痛。80%的受访者担心自己的整体健康状况。超过 60%的受访者表示他们经历过焦虑和/或抑郁。在这项调查中，尽管所有受访者由于头痛频率都有资格接受预防头痛/偏头痛药物治疗，但只有 15%的人在服用。
这项调查结果表明，在头痛/偏头痛护理方面有很多需要改进的地方，包括讨论心理和情绪健康、确保治疗方案有效且没有无法忍受的副作用，以及努力预防头痛/偏头痛的发生。
